ARK Investment Management has acquired a 5.54% stake in Prime Medicine, signaling increased interest in the biological products sector.
| Name | Prime Medicine, Inc. |
|---|---|
| CIK | 0001894562 |
| Tickers | PRME |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company |
| SIC | 2836 Biological Products, (No Diagnostic Substances) |
| EIN | 000000000 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | 617-465-0013 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
ARK Investment Management has acquired a 5.54% stake in Prime Medicine, signaling increased interest in the biological products sector.
Prime Medicine, Inc. announces a public offering of 35.7 million shares to raise approximately $125 million, boosting its financial position.
Prime Medicine, Inc. releases Q3 results, highlighting growth strategies in the biological products sector, impacting industry dynamics and competition.
Prime Medicine, Inc. announces a public offering of 35.7 million shares, aiming to raise $134.7 million for R&D in Wilson disease and alpha-1 antitrypsin deficiency.
Prime Medicine, Inc. has filed a preliminary prospectus for a $125 million offering of common stock to fund growth in the biological products sector.
Prime Medicine, Inc. announces preliminary cash estimates of $61.2 million, signaling a strong liquidity position amid ongoing developments in gene editing.
306 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-13 | SCHEDULE 13D/A | xslSCHEDULE_13D_X02/primary_doc.xml | 0001193125-26-460600 | 005-93800 | 261552316 | 34 | 25322 | |||
| 2026-11-13 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-126830 | 005-93800 | 261550672 | 34 | 13073 | |||
| 2026-11-12 | 10-Q | 10-Q | 0001628280-26-073392 | 001-41536 | 261547064 | 34 | 5395826 | 1 | 1 | |
| 2026-11-12 | 8-K | 8-K | 2.02 | 0001628280-26-073372 | 001-41536 | 261546831 | 34 | 233961 | 1 | 1 |
| 2026-11-12 | 8-K | 8-K | 1.01 | 0001628280-26-073131 | 001-41536 | 261543461 | 34 | 501422 | 1 | 1 |
| 2026-11-12 | 424B5 | 424B5 | 0001628280-26-073125 | 333-291348 | 261543431 | 33 | 565260 | |||
| 2026-11-10 | 424B5 | 424B5 | 0001628280-26-072802 | 333-291348 | 261541166 | 33 | 557524 | |||
| 2026-11-10 | 8-K | 8-K | 2.02,8.01,9.01 | 0001628280-26-072713 | 001-41536 | 261540327 | 34 | 6818469 | 1 | 1 |
| 2026-08-06 | 10-Q | 10-Q | 0001628280-26-053883 | 001-41536 | 261246127 | 34 | 5163262 | 1 | 1 | |
| 2026-08-06 | 8-K | 8-K | 2.02,9.01 | 0001628280-26-053878 | 001-41536 | 261246116 | 34 | 230691 | 1 | 1 |
| 2026-07-08 | 8-K | 8-K | 8.01 | 0001628280-26-047590 | 001-41536 | 261160797 | 34 | 140625 | 1 | 1 |
| 2026-06-08 | 4 | FORM 4 | 0001628280-26-041579 | 5484 | ||||||
| 2026-06-08 | 4 | FORM 4 | 0001628280-26-041575 | 5477 | ||||||
| 2026-06-08 | 4 | FORM 4 | 0001628280-26-041572 | 5457 | ||||||
| 2026-06-08 | 4 | FORM 4 | 0001628280-26-041569 | 5487 | ||||||
| 2026-06-08 | 4 | FORM 4 | 0001628280-26-041566 | 5495 | ||||||
| 2026-06-08 | 4 | FORM 4 | 0001628280-26-041560 | 5463 | ||||||
| 2026-06-08 | 4 | FORM 4 | 0001628280-26-041553 | 5467 | ||||||
| 2026-06-08 | 8-K | 8-K | 5.07 | 0001628280-26-041543 | 001-41536 | 261072719 | 34 | 185976 | 1 | 1 |
| 2026-05-07 | 10-Q | 10-Q | 0001628280-26-031726 | 001-41536 | 26950997 | 34 | 4641607 | 1 | 1 | |
| 2026-05-07 | 8-K | 8-K | 2.02,9.01 | 0001628280-26-031719 | 001-41536 | 26950980 | 34 | 224391 | 1 | 1 |
| 2026-04-23 | ARS | ARS | 0001628280-26-026704 | 001-41536 | 26885792 | 34 | 33162820 | |||
| 2026-04-23 | DEFA14A | DEFA14A | 0001628280-26-026701 | 001-41536 | 26885745 | 34 | 483907 | |||
| 2026-04-23 | DEF 14A | DEF 14A | 0001628280-26-026697 | 001-41536 | 26885734 | 34 | 1309937 | 1 | 1 | |
| 2026-04-17 | 4 | FORM 4 | 0001470831-26-000388 | 5503 | ||||||
| 2026-04-17 | 3 | FORM 3 | 0001470831-26-000386 | 427092 | ||||||
| 2026-04-16 | 8-K | 8-K | 5.02 | 0001628280-26-025372 | 001-41536 | 26865756 | 34 | 280012 | 1 | 1 |
| 2026-03-04 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-000723 | 333-291348 | 26724020 | 33 | 1721 | ||
| 2026-03-03 | S-8 | S-8 | 0001628280-26-013575 | 333-293959 | 26711155 | 33 | 184503 | 1 | 1 | |
| 2026-03-03 | POS AM | POS AM | 0001894562-26-000009 | 333-291348 | 26711144 | 33 | 573600 | |||
| 2026-03-03 | 10-K | 10-K | 0001628280-26-013569 | 001-41536 | 26711119 | 34 | 9790035 | 1 | 1 | |
| 2026-03-03 | POSASR | POSASR | 0001894562-26-000007 | 333-291348 | 26711111 | 33 | 812060 | 1 | 1 | |
| 2026-03-03 | 8-K | 8-K | 2.02,7.01,9.01 | 0001628280-26-013565 | 001-41536 | 26711100 | 34 | 6603016 | 1 | 1 |
| 2026-02-27 | 4 | FORM 4 | 0001628280-26-012893 | 5410 | ||||||
| 2026-02-24 | 4 | FORM 4 | 0001628280-26-011208 | 5391 | ||||||
| 2026-02-24 | 4 | FORM 4 | 0001628280-26-011181 | 5435 | ||||||
| 2026-02-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001897612-26-000293 | 005-93800 | 26637804 | 34 | 7515 | |||
| 2026-01-12 | 8-K | 8-K | 7.01,9.01 | 0001628280-26-001773 | 001-41536 | 26524821 | 34 | 6528915 | 1 | 1 |
| 2025-11-14 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001897612-25-000555 | 005-93800 | 251483388 | 34 | 7308 | |||
| 2025-11-12 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001845041-25-000005 | 005-93800 | 251473423 | 34 | 40534 | |||
| 2025-11-07 | S-3ASR | S-3ASR | 0001628280-25-050428 | 333-291348 | 251460585 | 33 | 1791099 | 1 | 1 | |
| 2025-11-07 | 10-Q | 10-Q | 0001628280-25-050422 | 001-41536 | 251460527 | 34 | 5911602 | 1 | 1 | |
| 2025-11-07 | 8-K | 8-K | 2.02,9.01 | 0001628280-25-050415 | 001-41536 | 251460510 | 34 | 229689 | 1 | 1 |
| 2025-11-05 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000315066-25-002807 | 005-93800 | 251452743 | 34 | 11201 | |||
| 2025-09-08 | 8-K | 8-K | 7.01,9.01 | 0001894562-25-000056 | 001-41536 | 251298632 | 34 | 6345973 | 1 | 1 |
| 2025-08-11 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001072613-25-000536 | 005-93800 | 251203823 | 34 | 61559 | |||
| 2025-08-07 | 10-Q | 10-Q | 0001628280-25-038619 | 001-41536 | 251191818 | 34 | 6312626 | 1 | 1 | |
| 2025-08-07 | 8-K | 8-K | 2.02,9.01 | 0001628280-25-038617 | 001-41536 | 251191804 | 34 | 232798 | 1 | 1 |
| 2025-08-05 | 4 | FORM 4 | 0001894562-25-000051 | 12613 | ||||||
| 2025-08-05 | 4 | FORM 4 | 0001894562-25-000050 | 12561 | ||||||
| 2025-08-05 | 4 | FORM 4 | 0001894562-25-000049 | 12534 | ||||||
| 2025-08-05 | 4 | FORM 4 | 0001894562-25-000048 | 16657 | ||||||
| 2025-08-05 | 4 | FORM 4 | 0001894562-25-000047 | 20754 | ||||||
| 2025-08-05 | 4 | FORM 4 | 0001894562-25-000046 | 20763 | ||||||
| 2025-08-05 | 4 | FORM 4 | 0001894562-25-000045 | 20730 | ||||||
| 2025-08-05 | 4 | FORM 4 | 0001894562-25-000044 | 12544 | ||||||
| 2025-08-05 | 4 | FORM 4 | 0001894562-25-000043 | 8525 | ||||||
| 2025-08-05 | 4 | FORM 4 | 0001894562-25-000042 | 416632 | ||||||
| 2025-08-05 | 8-K | 8-K | 5.02,5.07 | 0001628280-25-037840 | 001-41536 | 251185333 | 34 | 190707 | 1 | 1 |
| 2025-08-05 | 4 | xslF345X05/form4-08052025_080848.xml | 0001415889-25-021025 | 11114 | ||||||
| 2025-08-01 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-25-013462 | 10423 | ||||||
| 2025-08-01 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-25-013461 | 12574 | ||||||
| 2025-08-01 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-25-013460 | 20345 | ||||||
| 2025-07-31 | 8-K | 8-K | 1.01,9.01 | 0001628280-25-037076 | 001-41536 | 251172742 | 34 | 482716 | 1 | 1 |
| 2025-07-31 | 424B5 | 424B5 | 0001628280-25-037072 | 333-275321 | 251172709 | 33 | 545717 | |||
| 2025-07-30 | 424B5 | 424B5 | 0001628280-25-036721 | 333-275321 | 251167212 | 33 | 540709 | |||
| 2025-07-30 | 8-K | 8-K | 2.02,8.01,9.01 | 0001628280-25-036705 | 001-41536 | 251166946 | 34 | 6325608 | 1 | 1 |
| 2025-07-15 | 8-K | 8-K | 5.02 | 0001628280-25-034971 | 001-41536 | 251124798 | 34 | 142455 | 1 | 1 |
| 2025-07-14 | DEF 14A | DEF 14A | 0001193125-25-158716 | 001-41536 | 251122125 | 34 | 621988 | |||
| 2025-07-02 | PRE 14A | PRE 14A | 0001193125-25-155000 | 001-41536 | 251101975 | 34 | 794975 | |||
| 2025-07-01 | 4 | FORM 4 | 0001628280-25-033754 | 5162 | ||||||
| 2025-06-23 | 4 | FORM 4 | 0001628280-25-032626 | 5161 | ||||||
| 2025-06-16 | 4 | FORM 4 | 0001628280-25-031637 | 5162 | ||||||
| 2025-06-12 | 4 | FORM 4 | 0001628280-25-031045 | 433985 | ||||||
| 2025-06-05 | 4 | FORM 4 | 0001628280-25-029774 | 435562 | ||||||
| 2025-06-05 | 4 | FORM 4 | 0001628280-25-029773 | 5340 | ||||||
| 2025-06-05 | 4 | FORM 4 | 0001628280-25-029772 | 434307 | ||||||
| 2025-06-05 | 4 | FORM 4 | 0001628280-25-029771 | 435083 | ||||||
| 2025-06-05 | 4 | FORM 4 | 0001628280-25-029770 | 433713 | ||||||
| 2025-06-05 | 4 | FORM 4 | 0001628280-25-029769 | 434494 | ||||||
| 2025-06-05 | 4 | FORM 4 | 0001628280-25-029768 | 435769 | ||||||
| 2025-06-05 | 8-K | 8-K | 5.07,9.01 | 0001628280-25-029646 | 001-41536 | 251027224 | 34 | 186440 | 1 | 1 |
| 2025-05-22 | 4 | FORM 4 | 0001894562-25-000030 | 4456 | ||||||
| 2025-05-22 | 4 | FORM 4 | 0001894562-25-000028 | 4458 | ||||||
| 2025-05-22 | 4 | FORM 4 | 0001894562-25-000026 | 5002 | ||||||
| 2025-05-19 | 4 | FORM 4 | 0001894562-25-000024 | 436643 | ||||||
| 2025-05-19 | 4 | FORM 4 | 0001894562-25-000023 | 5405 | ||||||
| 2025-05-19 | DEFA14A | DEFA14A | 0001193125-25-122158 | 001-41536 | 25961814 | 34 | 16355311 | |||
| 2025-05-19 | 8-K | 8-K | 5.02,7.01,8.01,9.01 | 0001193125-25-122156 | 001-41536 | 25961795 | 34 | 16514054 | 1 | 1 |
| 2025-05-12 | 4 | FORM 4 | 0001894562-25-000020 | 434662 | ||||||
| 2025-05-12 | 4 | FORM 4 | 0001894562-25-000019 | 437753 | ||||||
| 2025-05-12 | 4 | FORM 4 | 0001894562-25-000018 | 434180 | ||||||
| 2025-05-08 | 10-Q | 10-Q | 0001628280-25-023486 | 001-41536 | 25923998 | 34 | 5356081 | 1 | 1 | |
| 2025-05-08 | 8-K | 8-K | 2.02,9.01 | 0001628280-25-023482 | 001-41536 | 25923986 | 34 | 238486 | 1 | 1 |
| 2025-04-22 | ARS | ARS | 0001628280-25-018708 | 001-41536 | 25854894 | 34 | 32100312 | |||
| 2025-04-22 | DEFA14A | DEFA14A | 0001628280-25-018706 | 001-41536 | 25854884 | 34 | 483243 | |||
| 2025-04-22 | DEF 14A | DEF 14A | 0001628280-25-018704 | 001-41536 | 25854875 | 34 | 751504 | |||
| 2025-03-18 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-25-056122 | 001-41536 | 25746486 | 34 | 18713407 | 1 | 1 |
| 2025-03-04 | 4 | FORM 4 | 0001894562-25-000014 | 5443 | ||||||
| 2025-03-03 | 4 | FORM 4 | 0001894562-25-000012 | 5440 | ||||||
| 2025-03-03 | 4 | FORM 4 | 0001894562-25-000010 | 5425 | ||||||
| 2025-03-03 | 4 | FORM 4 | 0001894562-25-000008 | 5410 | ||||||
| 2025-03-03 | 4 | FORM 4 | 0001894562-25-000006 | 5399 | ||||||
| 2025-03-03 | 4 | FORM 4 | 0001894562-25-000004 | 5409 | ||||||
| 2025-03-03 | 4 | FORM 4 | 0001894562-25-000002 | 5415 | ||||||
| 2025-02-28 | S-8 | S-8 | 0001628280-25-008885 | 333-285396 | 25682858 | 33 | 100200 | |||
| 2025-02-28 | 10-K | 10-K | 0001628280-25-008884 | 001-41536 | 25682824 | 34 | 17872579 | 1 | 1 | |
| 2025-02-28 | 8-K | 8-K | 2.02,9.01 | 0001628280-25-008873 | 001-41536 | 25682800 | 34 | 237457 | 1 | 1 |
| 2025-02-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001493152-25-006876 | 005-93800 | 25628935 | 34 | 10952 | |||
| 2025-01-13 | 8-K | 8-K | 7.01,9.01 | 0001628280-25-001244 | 001-41536 | 25524879 | 34 | 6224703 | 1 | 1 |
| 2024-12-20 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-24-003900 | 333-283780 | 241569588 | 33 | 1716 | ||
| 2024-12-18 | CORRESP | filename1.htm | 0001193125-24-281271 | 6436 | ||||||
| 2024-12-17 | UPLOAD | filename1.pdf | 0000000000-24-013902 | 333-283780 | 39901 | |||||
| 2024-12-13 | S-3 | S-3 | 0001628280-24-051126 | 333-283780 | 241546871 | 33 | 287745 | |||
| 2024-12-09 | 4 | FORM 4 | 0001894562-24-000049 | 5675 | ||||||
| 2024-12-09 | 4 | FORM 4 | 0001894562-24-000048 | 5535 | ||||||
| 2024-12-09 | 4 | FORM 4 | 0001894562-24-000047 | 5544 | ||||||
| 2024-11-22 | SC 13D/A | ARCH VENTURE FUND XII, L.P. - PRIME MEDICINE -- SCH 13D/A(#1) | 0001072613-24-000898 | 005-93800 | 241491086 | 34 | 437591 | |||
| 2024-11-12 | 10-Q | 10-Q | 0001628280-24-047130 | 001-41536 | 241448159 | 34 | 7049017 | 1 | 1 | |
| 2024-11-12 | 8-K | 8-K | 2.02,9.01 | 0001628280-24-047119 | 001-41536 | 241448028 | 34 | 240396 | 1 | 1 |
| 2024-11-12 | SC 13G/A | filing.txt | 0000315066-24-002848 | 005-93800 | 241444970 | 34 | 7757 | |||
| 2024-10-24 | 8-K | 8-K | 7.01,9.01 | 0001628280-24-043500 | 001-41536 | 241390783 | 34 | 186516 | 1 | 1 |
| 2024-10-10 | 4 | FORM 4 | 0001894562-24-000043 | 8568 | ||||||
| 2024-10-04 | SC 13G | SC 13G | 0001140361-24-042895 | 005-93800 | 241355158 | 34 | 51826 | |||
| 2024-09-30 | 8-K | 8-K | 1.01,3.02,7.01,9.01 | 0001628280-24-041541 | 001-41536 | 241336686 | 34 | 7179514 | 1 | 1 |
| 2024-08-08 | 10-Q | 10-Q | 0001628280-24-035893 | 001-41536 | 241186218 | 34 | 5040873 | 1 | 1 | |
| 2024-08-08 | 8-K | 8-K | 2.02,9.01 | 0001628280-24-035886 | 001-41536 | 241186180 | 34 | 228286 | 1 | 1 |
| 2024-06-14 | 4 | FORM 4 | 0001894562-24-000041 | 5348 | ||||||
| 2024-06-14 | 4 | FORM 4 | 0001894562-24-000040 | 5355 | ||||||
| 2024-06-14 | 4 | FORM 4 | 0001894562-24-000039 | 5328 | ||||||
| 2024-06-14 | 4 | FORM 4 | 0001894562-24-000038 | 5358 | ||||||
| 2024-06-14 | 4 | FORM 4 | 0001894562-24-000037 | 5367 | ||||||
| 2024-06-14 | 4 | FORM 4 | 0001894562-24-000036 | 5335 | ||||||
| 2024-06-14 | 4 | FORM 4 | 0001894562-24-000035 | 5339 | ||||||
| 2024-06-12 | 8-K | 8-K | 5.03,5.07,9.01 | 0001628280-24-027816 | 001-41536 | 241038515 | 34 | 230839 | 1 | 1 |
| 2024-06-07 | 4 | FORM 4 | 0001894562-24-000026 | 8550 | ||||||
| 2024-05-21 | 4 | FORM 4 | 0001894562-24-000024 | 5539 | ||||||
| 2024-05-21 | 4 | FORM 4 | 0001894562-24-000023 | 5527 | ||||||
| 2024-05-21 | 4 | FORM 4 | 0001894562-24-000022 | 5520 | ||||||
| 2024-05-21 | DEFA14A | DEFA14A | 0001628280-24-024535 | 001-41536 | 24969350 | 34 | 35772 | |||
| 2024-05-21 | 8-K | 8-K | 5.03,9.01 | 0001628280-24-024530 | 001-41536 | 24969241 | 34 | 339030 | 1 | 1 |
| 2024-05-10 | 10-Q | 10-Q | 0001628280-24-022473 | 001-41536 | 24932954 | 34 | 4696256 | 1 | 1 | |
| 2024-05-10 | 8-K | 8-K | 2.02,9.01 | 0001628280-24-022466 | 001-41536 | 24932937 | 34 | 239638 | 1 | 1 |
| 2024-04-29 | ARS | ARS | 0001628280-24-018992 | 001-41536 | 24890681 | 34 | 33496991 | |||
| 2024-04-29 | DEFA14A | DEFA14A | 0001628280-24-018983 | 001-41536 | 24890574 | 34 | 503590 | |||
| 2024-04-29 | DEF 14A | DEF 14A | 0001628280-24-018977 | 001-41536 | 24890543 | 34 | 791412 | |||
| 2024-04-19 | PRE 14A | DEF 14A | 0001628280-24-016946 | 001-41536 | 24857803 | 34 | 722521 | |||
| 2024-03-04 | 4 | FORM 4 | 0001894562-24-000018 | 5284 | ||||||
| 2024-03-01 | S-8 | S-8 | 0001628280-24-008117 | 333-277567 | 24707045 | 33 | 98786 | |||
| 2024-03-01 | 10-K | 10-K | 0001628280-24-008116 | 001-41536 | 24707034 | 34 | 18813550 | 1 | 1 | |
| 2024-03-01 | 8-K | 8-K | 2.02,9.01 | 0001628280-24-008113 | 001-41536 | 24707021 | 34 | 237806 | 1 | 1 |
| 2024-02-29 | 3 | xslF345X02/form3-02292024_090209.xml | 0001415889-24-005874 | 10180 | ||||||
| 2024-02-29 | SC 13G/A | SC 13G/A | 0001104659-24-029377 | 005-93800 | 24703837 | 34 | 233113 | |||
| 2024-02-27 | 4 | FORM 4 | 0001894562-24-000016 | 5734 | ||||||
| 2024-02-23 | 4 | FORM 4 | 0001894562-24-000014 | 5406 | ||||||
| 2024-02-23 | 4 | FORM 4 | 0001894562-24-000013 | 5407 | ||||||
| 2024-02-23 | 4 | FORM 4 | 0001894562-24-000012 | 5396 | ||||||
| 2024-02-23 | 4 | FORM 4 | 0001894562-24-000011 | 5422 | ||||||
| 2024-02-23 | 4 | FORM 4 | 0001894562-24-000010 | 5437 | ||||||
| 2024-02-22 | SC 13D | ARCH VENTURE FUND XII, L.P. - PRIME MEDICINE -- SCH 13D | 0001072613-24-000265 | 005-93800 | 24667079 | 34 | 448606 | |||
| 2024-02-20 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-003740 | 10427 | ||||||
| 2024-02-20 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-003739 | 12576 | ||||||
| 2024-02-20 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-003738 | 20342 | ||||||
| 2024-02-16 | 8-K | 8-K | 1.01,9.01 | 0001193125-24-038016 | 001-41536 | 24645712 | 34 | 554809 | 1 | 1 |
| 2024-02-16 | 424B5 | 424B5 | 0001628280-24-005201 | 333-275321 | 24645704 | 33 | 1312182 | |||
| 2024-02-15 | FWP | FWP | 0001628280-24-004927 | 333-275321 | 24641872 | 34 | 145295 | |||
| 2024-02-14 | 424B5 | 424B5 | 0001628280-24-004859 | 333-275321 | 24640781 | 33 | 1272956 | |||
| 2024-02-14 | 8-K | 8-K | 2.02 | 0001628280-24-004785 | 001-41536 | 24638251 | 34 | 158623 | 1 | 1 |
| 2024-02-09 | SC 13G/A | SC 13G/A | 0001104659-24-012941 | 005-93800 | 24614902 | 34 | 177037 | |||
| 2024-02-09 | SC 13G/A | filing.txt | 0000315066-24-001470 | 005-93800 | 24612077 | 34 | 7883 | |||
| 2024-01-19 | 4 | FORM 4 | 0001894562-24-000004 | 5417 | ||||||
| 2024-01-19 | 3 | FORM 3 | 0001894562-24-000003 | 7530 | ||||||
| 2024-01-08 | 8-K | 8-K | 7.01,9.01 | 0001193125-24-003924 | 001-41536 | 24518401 | 34 | 14938724 | 1 | 1 |
| 2024-01-05 | 8-K | 8-K | 8.01 | 0001628280-24-000676 | 001-41536 | 24517393 | 34 | 152759 | 1 | 1 |
| 2024-01-05 | 8-K | 8-K | 5.02,9.01 | 0001628280-24-000524 | 001-41536 | 24514483 | 34 | 290637 | 1 | 1 |
| 2023-11-14 | 4 | FORM 4 | 0001894562-23-000034 | 8573 | ||||||
| 2023-11-13 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2023-11-13 16:01:00 | 9999999995-23-003310 | 333-275321 | 231401271 | 33 | 1665 | ||
| 2023-11-09 | CORRESP | filename1.htm | 0001193125-23-274699 | 6239 | ||||||
| 2023-11-07 | UPLOAD | filename1.pdf | 0000000000-23-012206 | 40136 | ||||||
| 2023-11-03 | S-3 | S-3 | 0001628280-23-036792 | 333-275321 | 231377419 | 33 | 1597527 | |||
| 2023-11-03 | 10-Q | 10-Q | 0001628280-23-036777 | 001-41536 | 231377295 | 34 | 4983174 | 1 | 1 | |
| 2023-11-03 | 8-K | 8-K | 2.02,9.01 | 0001628280-23-036706 | 001-41536 | 231376333 | 34 | 245313 | 1 | 1 |
| 2023-08-07 | 10-Q | 10-Q | 0001628280-23-027772 | 001-41536 | 231147694 | 34 | 17155188 | 1 | 1 | |
| 2023-08-07 | 8-K | 8-K | 2.02,7.01,9.01 | 0001628280-23-027756 | 001-41536 | 231147528 | 34 | 5731894 | 1 | 1 |
| 2023-07-26 | 4/A | FORM 4/A | 0001894562-23-000032 | 4803 | ||||||
| 2023-07-25 | 4 | FORM 4 | 0001894562-23-000030 | 4439 | ||||||
| 2023-06-22 | 4 | FORM 4 SUBMISSION | 0001209191-23-039122 | 24320 | ||||||
| 2023-06-20 | 144 | xsl144X01/primary_doc.xml | 0001974078-23-000075 | 001-41536 | 231026107 | 33 | 16971 | |||
| 2023-06-20 | 4 | FORM 4 SUBMISSION | 0001209191-23-038363 | 24319 | ||||||
| 2023-06-16 | 4 | FORM 4 | 0001894562-23-000028 | 5352 | ||||||
| 2023-06-16 | 4 | FORM 4 | 0001894562-23-000027 | 5369 | ||||||
| 2023-06-16 | 4 | FORM 4 | 0001894562-23-000026 | 5381 | ||||||
| 2023-06-16 | 4 | FORM 4 | 0001894562-23-000025 | 5351 | ||||||
| 2023-06-16 | 4 | FORM 4 | 0001894562-23-000024 | 5372 | ||||||
| 2023-06-16 | 4 | FORM 4 | 0001894562-23-000023 | 5348 | ||||||
| 2023-06-16 | 8-K | 8-K | 5.07 | 0001628280-23-022447 | 001-41536 | 231020886 | 34 | 182626 | 1 | 1 |
| 2023-06-15 | 4 | FORM 4 SUBMISSION | 0001209191-23-037334 | 24320 | ||||||
| 2023-06-13 | 4 | FORM 4 SUBMISSION | 0001209191-23-036666 | 24321 | ||||||
| 2023-06-12 | 144 | xsl144X01/primary_doc.xml | 0001974078-23-000065 | 001-41536 | 231008862 | 33 | 13391 | |||
| 2023-06-09 | 4 | FORM 4 SUBMISSION | 0001209191-23-035849 | 24322 | ||||||
| 2023-06-07 | 4 | FORM 4 SUBMISSION | 0001209191-23-035068 | 24313 | ||||||
| 2023-06-05 | 144 | xsl144X01/primary_doc.xml | 0001974078-23-000056 | 001-41536 | 23993506 | 33 | 10373 | |||
| 2023-06-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-033697 | 26295 | ||||||
| 2023-05-31 | 4 | FORM 4 SUBMISSION | 0001209191-23-033107 | 24315 | ||||||
| 2023-05-30 | 144 | xsl144X01/primary_doc.xml | 0001974078-23-000054 | 001-41536 | 23977242 | 33 | 9196 | |||
| 2023-05-26 | 4 | FORM 4 SUBMISSION | 0001209191-23-032529 | 24311 | ||||||
| 2023-05-24 | 4 | FORM 4 SUBMISSION | 0001209191-23-031916 | 24315 | ||||||
| 2023-05-22 | 4 | FORM 4 SUBMISSION | 0001209191-23-031450 | 26293 | ||||||
| 2023-05-18 | 144 | xsl144X01/primary_doc.xml | 0001974078-23-000039 | 001-41536 | 23936501 | 33 | 9843 | |||
| 2023-05-18 | 4 | FORM 4 SUBMISSION | 0001209191-23-030621 | 19656 | ||||||
| 2023-05-17 | 8-K | 8-K | 7.01,9.01 | 0001628280-23-018552 | 001-41536 | 23929617 | 34 | 213430 | 1 | 1 |
| 2023-05-16 | 4 | FORM 4 SUBMISSION | 0001209191-23-029789 | 19655 | ||||||
| 2023-05-12 | 4 | FORM 4 | 0001894562-23-000014 | 5292 | ||||||
| 2023-05-12 | 3 | FORM 3 | 0001894562-23-000013 | 7729 | ||||||
| 2023-05-12 | 4 | FORM 4 SUBMISSION | 0001209191-23-029033 | 21634 | ||||||
| 2023-05-11 | 10-Q | 10-Q | 0001628280-23-017423 | 001-41536 | 23908988 | 34 | 5311738 | 1 | 1 | |
| 2023-05-11 | DEFA14A | DEFA14A | 0001628280-23-017421 | 001-41536 | 23908950 | 34 | 33443 | |||
| 2023-05-11 | 8-K | 8-K | 5.02 | 0001628280-23-017420 | 001-41536 | 23908946 | 34 | 176371 | 1 | 1 |
| 2023-05-11 | 8-K | 8-K | 2.02,9.01 | 0001628280-23-017419 | 001-41536 | 23908942 | 34 | 246932 | 1 | 1 |
| 2023-05-10 | 4 | FORM 4 SUBMISSION | 0001209191-23-028464 | 24057 | ||||||
| 2023-05-08 | 144 | xsl144X01/primary_doc.xml | 0001974078-23-000006 | 001-41536 | 23899152 | 33 | 5404 | |||
| 2023-04-28 | ARS | ARS | 0001628280-23-013832 | 001-41536 | 23860622 | 34 | 20865441 | |||
| 2023-04-28 | DEFA14A | DEFA14A | 0001628280-23-013821 | 001-41536 | 23860572 | 34 | 458197 | |||
| 2023-04-28 | DEF 14A | DEF 14A | 0001628280-23-013811 | 001-41536 | 23860549 | 34 | 519282 | |||
| 2023-04-20 | 4 | FORM 4 | 0001894562-23-000010 | 5328 | ||||||
| 2023-04-20 | 4 | FORM 4 | 0001894562-23-000008 | 5390 | ||||||
| 2023-04-04 | 4 | FORM 4 | 0001894562-23-000006 | 5392 | ||||||
| 2023-04-04 | 4 | FORM 4 | 0001894562-23-000005 | 5377 | ||||||
| 2023-04-04 | 4 | FORM 4 | 0001894562-23-000004 | 5376 | ||||||
| 2023-04-04 | 4 | FORM 4 | 0001894562-23-000003 | 5410 | ||||||
| 2023-04-04 | 4 | FORM 4 | 0001894562-23-000002 | 5366 | ||||||
| 2023-04-04 | 4 | FORM 4 | 0001894562-23-000001 | 5390 | ||||||
| 2023-03-10 | 8-K/A | 8-K/A | 2.02,9.01 | 0001193125-23-066791 | 001-41536 | 23721667 | 34 | 231438 | 1 | 1 |
| 2023-03-09 | S-8 | S-8 | 0001628280-23-007302 | 333-270400 | 23719978 | 33 | 126381 | |||
| 2023-03-09 | 10-K | 10-K | 0001628280-23-007266 | 001-41536 | 23719367 | 34 | 166316539 | 1 | 1 | |
| 2023-03-09 | 8-K | 8-K | 2.02,9.01 | 0001193125-23-065373 | 001-41536 | 23718275 | 34 | 223754 | 1 | 1 |
| 2023-02-13 | SC 13G | ARCH VENTURE FUND X, L.P. - PRIME MEDICINE, INC. -- SCH 13G | 0001072613-23-000104 | 005-93800 | 23618428 | 34 | 298173 | |||
| 2023-02-10 | SC 13G | SC 13G | 0001104659-23-018498 | 005-93800 | 23611781 | 34 | 218455 | |||
| 2023-02-09 | SC 13G/A | filing.txt | 0000315066-23-001354 | 005-93800 | 23601211 | 34 | 7750 | |||
| 2023-02-07 | SC 13G | SC 13G | 0001193125-23-027015 | 005-93800 | 23595721 | 34 | 81739 | |||
| 2023-01-09 | 8-K | FORM 8-K | 7.01,9.01 | 0001193125-23-004734 | 001-41536 | 23518094 | 34 | 9904417 | 1 | 1 |
| 2022-11-14 | 10-Q | 10-Q | 0001628280-22-029889 | 001-41536 | 221386881 | 34 | 8081636 | 1 | 1 | |
| 2022-10-26 | 4 | FORM 4 | 0001628280-22-027126 | 24597 | ||||||
| 2022-10-26 | 4 | FORM 4 | 0001628280-22-027125 | 32398 | ||||||
| 2022-10-26 | 4 | FORM 4 | 0001628280-22-027124 | 24036 | ||||||
| 2022-10-26 | 4 | FORM 4 | 0001628280-22-027123 | 6880 | ||||||
| 2022-10-26 | 4 | FORM 4 | 0001628280-22-027122 | 11773 | ||||||
| 2022-10-26 | 4 | PRIMARY DOCUMENT | 0000315066-22-001801 | 24903 | ||||||
| 2022-10-26 | SC 13G | filing.txt | 0000315066-22-001800 | 005-93800 | 221331692 | 34 | 7505 | |||
| 2022-10-24 | 8-K | 8-K | 5.03,9.01 | 0001628280-22-026895 | 001-41536 | 221326383 | 34 | 207829 | ||
| 2022-10-24 | 3/A | FORM 3/A | 0001628280-22-026890 | 4883 | ||||||
| 2022-10-21 | 424B4 | 424B4 | 0001628280-22-026826 | 333-267579 | 221324200 | 33 | 95409289 | |||
| 2022-10-21 | 4 | FORM 4 | 0001628280-22-026824 | 5248 | ||||||
| 2022-10-21 | 4 | FORM 4 | 0001628280-22-026823 | 5281 | ||||||
| 2022-10-21 | 4 | FORM 4 | 0001628280-22-026822 | 5272 | ||||||
| 2022-10-20 | FWP | FWP | 0001628280-22-026673 | 333-267579 | 221319505 | 34 | 8863 | |||
| 2022-10-19 | SEC STAFF LETTER | filename1.pdf | 9999999997-22-004558 | 275198 | ||||||
| 2022-10-19 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2022-10-19 16:00:00 | 9999999995-22-003086 | 333-267579 | 221319663 | 33 | 1665 | ||
| 2022-10-19 | 3 | PRIMARY DOCUMENT | 0000315066-22-001797 | 11228 | ||||||
| 2022-10-19 | 3 | FORM 3 | 0001628280-22-026690 | 7473 | ||||||
| 2022-10-19 | 3 | FORM 3 | 0001628280-22-026689 | 26177 | ||||||
| 2022-10-19 | 3 | FORM 3 | 0001628280-22-026688 | 17787 | ||||||
| 2022-10-19 | 3 | FORM 3 | 0001628280-22-026687 | 8954 | ||||||
| 2022-10-19 | 3 | FORM 3 | 0001628280-22-026686 | 8852 | ||||||
| 2022-10-19 | 3 | FORM 3 | 0001628280-22-026685 | 10020 | ||||||
| 2022-10-19 | 3 | FORM 3 | 0001628280-22-026684 | 10923 | ||||||
| 2022-10-19 | 3 | FORM 3 | 0001628280-22-026683 | 9520 | ||||||
| 2022-10-19 | 3 | FORM 3 | 0001628280-22-026682 | 10166 | ||||||
| 2022-10-19 | 3 | FORM 3 | 0001628280-22-026681 | 11448 | ||||||
| 2022-10-19 | 3 | FORM 3 | 0001628280-22-026680 | 12358 | ||||||
| 2022-10-19 | 3 | FORM 3 | 0001628280-22-026679 | 8801 | ||||||
| 2022-10-19 | 3 | FORM 3 | 0001628280-22-026678 | 14048 | ||||||
| 2022-10-19 | 3 | FORM 3 | 0001628280-22-026677 | 11071 | ||||||
| 2022-10-19 | 3 | FORM 3 | 0001628280-22-026676 | 9514 | ||||||
| 2022-10-19 | S-1MEF | S-1MEF | 0001628280-22-026665 | 333-267954 | 221319452 | 33 | 72370 | |||
| 2022-10-19 | S-8 | S-8 | 0001628280-22-026643 | 333-267953 | 221319289 | 33 | 107924 | |||
| 2022-10-19 | CERT | 8A_Cert_PRME.pdf | 0001354457-22-000578 | 001-41536 | 221317550 | 34 | 185812 | |||
| 2022-10-17 | 8-A12B | 8-A12B | 0001628280-22-026508 | 001-41536 | 221314161 | 34 | 18318 | |||
| 2022-10-17 | CORRESP | filename1.htm | 0001628280-22-026501 | 19623 | ||||||
| 2022-10-17 | CORRESP | filename1.htm | 0001628280-22-026500 | 12702 | ||||||
| 2022-10-17 | FWP | FWP | 0001628280-22-026499 | 333-267579 | 221313799 | 34 | 8963 | |||
| 2022-10-17 | CORRESP | filename1.htm | 0001628280-22-026492 | 13572 | ||||||
| 2022-10-17 | S-1/A | S-1/A | 0001628280-22-026491 | 333-267579 | 221313512 | 33 | 95519488 | |||
| 2022-10-14 | UPLOAD | filename1.pdf | 0000000000-22-011336 | 44159 | ||||||
| 2022-10-13 | CORRESP | filename1.htm | 0001628280-22-026331 | 16177 | ||||||
| 2022-10-13 | S-1/A | S-1/A | 0001628280-22-026329 | 333-267579 | 221308401 | 33 | 98631141 | |||
| 2022-10-07 | CORRESP | filename1.htm | 0001628280-22-026153 | 28858 | ||||||
| 2022-09-30 | UPLOAD | filename1.pdf | 0000000000-22-010796 | 46046 | ||||||
| 2022-09-23 | S-1 | S-1 | 0001628280-22-025424 | 333-267579 | 221262475 | 33 | 102400306 | |||
| 2022-08-05 | DRS/A | filename1.htm | 0001628279-22-000370 | 377-05831 | 221140579 | 33 | 96546228 | |||
| 2022-05-06 | DRS/A | filename1.htm | 0001628279-22-000257 | 377-05831 | 22901108 | 33 | 75141918 | |||
| 2022-04-11 | SEC STAFF LETTER | filename1.pdf | 9999999997-22-001572 | 275980 | ||||||
| 2022-04-08 | DRSLTR | filename1.htm | 0001628279-22-000192 | 17536 | ||||||
| 2022-04-08 | DRS/A | filename1.htm | 0001628279-22-000190 | 377-05831 | 22816827 | 33 | 74417487 | |||
| 2022-03-30 | UPLOAD | filename1.pdf | 0000000000-22-003481 | 46527 | ||||||
| 2022-03-25 | DRSLTR | filename1.htm | 0001628279-22-000146 | 27045 | ||||||
| 2022-03-25 | DRS/A | filename1.htm | 0001628279-22-000144 | 377-05831 | 22771224 | 33 | 74234408 | |||
| 2022-03-15 | UPLOAD | filename1.pdf | 0000000000-22-002823 | 50159 | ||||||
| 2022-03-07 | DRSLTR | filename1.htm | 0001628279-22-000119 | 67690 | ||||||
| 2022-03-07 | DRS/A | filename1.htm | 0001628279-22-000118 | 377-05831 | 22719210 | 33 | 75085111 | |||
| 2022-02-17 | UPLOAD | filename1.pdf | 0000000000-22-001948 | 72114 | ||||||
| 2022-02-04 | DRSLTR | filename1.htm | 0001628279-22-000058 | 185012 | ||||||
| 2022-02-04 | DRS/A | filename1.htm | 0001628279-22-000057 | 377-05831 | 22594408 | 33 | 76402604 | |||
| 2022-01-18 | UPLOAD | filename1.pdf | 0000000000-22-000596 | 83125 | ||||||
| 2022-01-12 | DRS/A | filename1.htm | 0001628279-22-000012 | 377-05831 | 22526198 | 33 | 3299727 | |||
| 2021-12-20 | DRS | filename1.htm | 0001628279-21-000794 | 377-05831 | 211506054 | 33 | 55802822 |
One latest value per concept from companyfacts (215 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 181.92M | 2026-10-31 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 238.76M | 2025-06-30 | 2025 | FY | 10-K | 2026-03-03 | 0001628280-26-013569 | |
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 6.39M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 | |
| us-gaap | AccountsReceivableGrossCurrent | Accounts Receivable, before Allowance for Credit Loss, Current | USD | 120,000 | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-07 | 0001628280-25-038619 | |
| us-gaap | AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments | USD | 1.07M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 |
| us-gaap | AccruedEmployeeBenefitsCurrent | Accrued Employee Benefits, Current | USD | 300,000 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-14 | 0001628280-22-029889 | |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 10.85M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 5.58M | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-12 | 0001628280-24-047130 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 25.83M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -3,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 1.03B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition | APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition | USD | 338,000 | 2026-04-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition | USD | 4.80M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalWarrantIssued | Adjustments to Additional Paid in Capital, Warrant Issued | USD | 18.80M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001628280-26-013569 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 14.31M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 25.69M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 |
| us-gaap | Assets | Assets | USD | 213.85M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 63.69M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 | |
| us-gaap | AssetsFairValueDisclosure | Assets, Fair Value Disclosure | USD | 60.63M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | USD | 3,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 | |
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 6.27M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate | Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value | USD | 98.47M | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0001628280-23-007266 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One | USD | 6.27M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 6.27M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesCurrent | Debt Securities, Available-for-sale, Current | USD | 6.27M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 0 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-06 | 0001628280-26-053883 |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 54.89M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 | |
| us-gaap | CashCashEquivalentsAndShortTermInvestments | Cash, Cash Equivalents, and Short-term Investments | USD | 61.20M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 68.58M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | -8.15M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 |
| us-gaap | CashEquivalentsAtCarryingValue | Cash Equivalents, at Carrying Value | USD | 120.50M | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0001628280-23-007266 | |
| us-gaap | CommonStockCapitalSharesReservedForFutureIssuance | Common Stock, Capital Shares Reserved for Future Issuance | shares | 7.62M | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0001628280-23-007266 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 775.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 181.39M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 181.39M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 2,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -130.36M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 |
| us-gaap | ContractWithCustomerLiabilityCurrent | Contract with Customer, Liability, Current | USD | 8.98M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 | |
| us-gaap | ContractWithCustomerLiabilityNoncurrent | Contract with Customer, Liability, Noncurrent | USD | 50.78M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 | |
| us-gaap | ConversionOfStockAmountConverted1 | Conversion of Stock, Amount Converted | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-01 | 0001628280-24-008116 |
| us-gaap | CurrentFederalTaxExpenseBenefit | Current Federal Tax Expense (Benefit) | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-01 | 0001628280-24-008116 |
| us-gaap | CurrentIncomeTaxExpenseBenefit | Current Income Tax Expense (Benefit) | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-01 | 0001628280-24-008116 |
| us-gaap | CurrentStateAndLocalTaxExpenseBenefit | Current State and Local Tax Expense (Benefit) | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-01 | 0001628280-24-008116 |
| us-gaap | DeferredFederalIncomeTaxExpenseBenefit | Deferred Federal Income Tax Expense (Benefit) | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-28 | 0001628280-25-008884 |
| us-gaap | DeferredIncomeTaxExpenseBenefit | Deferred Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-07 | 0001628280-25-038619 |
| us-gaap | DeferredIncomeTaxLiabilities | Deferred Tax Liabilities, Gross | USD | 34.49M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001628280-26-013569 | |
| us-gaap | DeferredIncomeTaxLiabilitiesNet | Deferred Income Tax Liabilities, Net | USD | 134,000 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-10 | 0001628280-24-022473 | |
| us-gaap | DeferredOfferingCosts | Deferred Offering Costs | USD | 0 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0001628280-23-007266 | |
| us-gaap | DeferredStateAndLocalIncomeTaxExpenseBenefit | Deferred State and Local Income Tax Expense (Benefit) | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-28 | 0001628280-25-008884 |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 273.90M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001628280-26-013569 | |
| us-gaap | DeferredTaxAssetsInProcessResearchAndDevelopment | Deferred Tax Assets, in Process Research and Development | USD | 50.09M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001628280-26-013569 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 116.78M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001628280-26-013569 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration | Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration | USD | 429.23M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001628280-26-013569 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration | Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration | USD | 421.88M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001628280-26-013569 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001628280-26-013569 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwards | Deferred Tax Assets, Tax Credit Carryforwards | USD | 30.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001628280-26-013569 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 11.31M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001628280-26-013569 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals | USD | 19.83M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001628280-26-013569 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 239.41M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001628280-26-013569 | |
| us-gaap | DeferredTaxLiabilities | Deferred Tax Liabilities, Net | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001628280-26-013569 | |
| us-gaap | DefinedContributionPlanCostRecognized | Defined Contribution Plan, Cost | USD | 100,000 | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-14 | 0001628280-22-029889 |
| us-gaap | DefinedContributionPlanEmployerMatchingContributionPercent | Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay | pure | 0.06 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0001628280-23-007266 |
| us-gaap | DefinedContributionPlanEmployerMatchingContributionPercentOfMatch | Defined Contribution Plan, Employer Matching Contribution, Percent of Match | pure | 0.5 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0001628280-23-007266 |
| us-gaap | DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization | USD | 5.40M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 |
| us-gaap | DividendsPreferredStockCash | Dividends, Preferred Stock, Cash | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0001628280-23-007266 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -0.73 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -0.73 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001628280-26-013569 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001628280-26-013569 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.223 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001628280-26-013569 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpense | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent | pure | -0.009 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001628280-26-013569 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | pure | -0.001 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001628280-26-013569 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | -0.003 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001628280-26-013569 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | -0.006 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001628280-26-013569 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001628280-26-013569 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Percent | pure | -0.026 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001628280-26-013569 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | pure | -0.023 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001628280-26-013569 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 5.34M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 | |
| us-gaap | EquitySecuritiesFvNi | Equity Securities, FV-NI | USD | 5.45M | 2023-12-31 | 2023 | FY | 10-K | 2024-03-01 | 0001628280-24-008116 | |
| us-gaap | EquitySecuritiesFvNiCost | Equity Securities, FV-NI, Cost | USD | 5.49M | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0001628280-23-007266 | |
| us-gaap | EquitySecuritiesFvNiUnrealizedGain | Equity Securities, FV-NI, Unrealized Gain | USD | 2.35M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0001628280-23-007266 |
| us-gaap | EquitySecuritiesFvNiUnrealizedGainLoss | Equity Securities, FV-NI, Unrealized Gain (Loss) | USD | 1.70M | 2023-01-01 | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-11 | 0001628280-23-017423 |
| us-gaap | EquitySecuritiesFvNiUnrealizedLoss | Equity Securities, FV-NI, Unrealized Loss | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0001628280-23-007266 |
| us-gaap | GainLossOnSaleOfPropertyPlantEquipment | Gain (Loss) on Disposition of Property Plant Equipment | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-28 | 0001628280-25-008884 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 38.47M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 |
| us-gaap | ImpairmentOfLongLivedAssetsToBeDisposedOf | Impairment of Long-Lived Assets to be Disposed of | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0001628280-23-007266 |
| us-gaap | IncomeLossAttributableToParent | Income (Loss) Attributable to Parent, before Tax | USD | -104.48M | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-07 | 0001628280-25-038619 |
| us-gaap | IncomeTaxesPaid | Income Taxes Paid | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-01 | 0001628280-24-008116 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001628280-26-013569 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 44.87M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001628280-26-013569 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -42.24M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001628280-26-013569 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | USD | 291,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001628280-26-013569 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | 633,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001628280-26-013569 |
| us-gaap | IncomeTaxReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | USD | 1.02M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001628280-26-013569 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001628280-26-013569 |
| us-gaap | IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | USD | 4.63M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001628280-26-013569 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | -2.38M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 |
| us-gaap | IncreaseDecreaseInAccountsReceivable | Increase (Decrease) in Accounts Receivable | USD | 0 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-06 | 0001628280-26-053883 |
| us-gaap | IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities | USD | -1.75M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 |
| us-gaap | IncreaseDecreaseInContractWithCustomerLiability | Increase (Decrease) in Contract with Customer, Liability | USD | -6.20M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 |
| us-gaap | IncreaseDecreaseInEquitySecuritiesFvNi | Increase (Decrease) in Equity Securities, FV-NI | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | -6.01M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | 1.20M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 |
| us-gaap | IncrementalCommonSharesAttributableToCallOptionsAndWarrants | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants | shares | 3.20M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001628280-26-013569 |
| us-gaap | InvestmentIncomeInterest | Investment Income, Interest | USD | 2.36M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 |
| us-gaap | LeaseCost | Lease, Cost | USD | 33.99M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001628280-26-013569 |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 168.19M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive | Lessee, Operating Lease, Liability, to be Paid, after Year Five | USD | 74.48M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001628280-26-013569 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 22.36M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 22.12M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001628280-26-013569 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 22.12M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 21.48M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 22.29M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 5.46M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 57.76M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 | |
| us-gaap | Liabilities | Liabilities | USD | 205.42M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 213.85M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 35.63M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 | |
| us-gaap | LiabilitiesFairValueDisclosure | Financial and Nonfinancial Liabilities, Fair Value Disclosure | USD | 12.02M | 2021-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0001628280-23-007266 | |
| us-gaap | LossContingencyDamagesSoughtValue | Loss Contingency, Damages Sought, Value | USD | 43.50M | 2023-10-01 | 2023-10-31 | 2023 | FY | 10-K | 2024-03-01 | 0001628280-24-008116 |
| us-gaap | LossContingencyReceivable | Loss Contingency, Receivable | USD | 10.80M | 2024-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001628280-26-013569 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 3.62M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | 108.67M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -120.44M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -130.27M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -130.27M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersDiluted | Net Income (Loss) Available to Common Stockholders, Diluted | USD | -130.27M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | 3.59M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 140.09M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -133.87M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 22.96M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001628280-26-013569 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 110.42M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 9.41M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 101.01M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 | |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 117.58M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 | |
| us-gaap | OperatingLeaseRightOfUseAssetAmortizationExpense | Operating Lease, Right-of-Use Asset, Amortization Expense | USD | 8.60M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 |
| us-gaap | OperatingLeasesRentExpenseNet | Operating Leases, Rent Expense, Net | USD | 1.00M | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0001628280-23-007266 |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.122 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001628280-26-013569 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 1.02M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 | |
| us-gaap | OtherAssetsCurrent | Other Assets, Current | USD | 376,000 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-06 | 0001628280-26-053883 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 3.28M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 | |
| us-gaap | OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax | USD | -85,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 |
| us-gaap | OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent | USD | -357,000 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0001628280-23-007266 |
| us-gaap | OtherNoncashIncomeExpense | Other Noncash Income (Expense) | USD | 0 | 2023-01-01 | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-11 | 0001628280-23-017423 |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | 160,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 10.10M | 2024-02-01 | 2024-02-29 | 2024 | FY | 10-K | 2025-02-28 | 0001628280-25-008884 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 558,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 |
| us-gaap | PaymentsToAcquireShortTermInvestments | Payments to Acquire Short-term Investments | USD | 31.02M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 |
| us-gaap | PreferredStockConvertibleSharesIssuable | PreferredStockConvertibleSharesIssuable | shares | 51.92M | 2021-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0001628280-23-007266 | |
| us-gaap | PreferredStockDividendsIncomeStatementImpact | Preferred Stock Dividends, Income Statement Impact | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-01 | 0001628280-24-008116 |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 19.21M | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-03 | 0001628280-23-036777 | |
| us-gaap | PrepaidExpenseCurrent | Prepaid Expense, Current | USD | 2.53M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 | |
| us-gaap | PrepaidRent | Prepaid Rent | USD | 100,000 | 2021-01-01 | 2022 | FY | 10-K | 2023-03-09 | 0001628280-23-007266 | |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-01 | 0001628280-24-008116 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 2.81M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 |
| us-gaap | ProceedsFromIssuanceOfWarrants | Proceeds from Issuance of Warrants | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001628280-26-013569 |
| us-gaap | ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments | Proceeds from Maturities, Prepayments and Calls of Short-term Investments | USD | 140.25M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 |
| us-gaap | ProceedsFromSaleOfOtherInvestments | Proceeds from Sale of Other Investments | USD | 5.40M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001628280-26-013569 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 470,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 41.45M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 15.62M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 | |
| us-gaap | RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty | Related Party Transaction, Expenses from Transactions with Related Party | USD | 300,000 | 2023-01-01 | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-11 | 0001628280-23-017423 |
| us-gaap | RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty | Related Party Transaction, Other Revenues from Transactions with Related Party | USD | 126,000 | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0001628280-23-007266 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 101.62M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 |
| us-gaap | ResearchAndDevelopmentInProcess | Research and Development in Process | USD | 0 | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0001628280-23-007266 |
| us-gaap | RestrictedCash | Restricted Cash | USD | 13.69M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 | |
| us-gaap | RestrictedCashNoncurrent | Restricted Cash, Noncurrent | USD | 13.69M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 | |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -1.02B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 | |
| us-gaap | RevenueFromContractWithCustomerExcludingAssessedTax | Revenue from Contract with Customer, Excluding Assessed Tax | USD | 6.22M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 |
| us-gaap | SaleOfStockNumberOfSharesIssuedInTransaction | Sale of Stock, Number of Shares Issued in Transaction | shares | 43.70M | 2025-08-01 | 2025-08-31 | 2025 | FY | 10-K | 2026-03-03 | 0001628280-26-013569 |
| us-gaap | SaleOfStockPricePerShare | Sale of Stock, Price Per Share | USD/shares | 3.3 | 2025-08-31 | 2025 | FY | 10-K | 2026-03-03 | 0001628280-26-013569 | |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 14.31M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 1.53M | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-07 | 0001628280-23-027772 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 4.08 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | shares | 1.39M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 7.27M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 21.39M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 3.55 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number | shares | 10.31M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares | 21.39M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | USD/shares | 3.55 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost | Share-based Payment Arrangement, Plan Modification, Incremental Cost | USD | 5.10M | 2025-08-01 | 2025 | FY | 10-K | 2026-03-03 | 0001628280-26-013569 | |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 3.54 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | USD/shares | 5.87 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 3.55 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 |
| us-gaap | ShortTermLeaseCost | Short-term Lease, Cost | USD | 1.80M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001628280-26-013569 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 8.44M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 0.322 | 2022-10-01 | 2022-10-31 | 2023 | FY | 10-K | 2024-03-01 | 0001628280-24-008116 |
| us-gaap | StockIssuedDuringPeriodSharesRestrictedStockAwardGross | Stock Issued During Period, Shares, Restricted Stock Award, Gross | shares | 2.00M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001628280-26-013569 |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 132,617 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 395.80M | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-01 | 0001628280-24-008116 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 138.38M | 2025-07-01 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-07 | 0001628280-25-050422 |
| us-gaap | StockIssuedDuringPeriodValueRestrictedStockAwardGross | Stock Issued During Period, Value, Restricted Stock Award, Gross | USD | 0 | 2025-07-01 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-07 | 0001628280-25-050422 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 54,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 |
| us-gaap | SubleaseIncome | Sublease Income | USD | 212,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001628280-26-013569 |
| us-gaap | TemporaryEquityAccretionToRedemptionValue | Temporary Equity, Accretion to Redemption Value | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0001628280-23-007266 |
| us-gaap | TemporaryEquityAccretionToRedemptionValueAdjustment | Temporary Equity, Accretion to Redemption Value, Adjustment | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0001628280-23-007266 |
| us-gaap | TemporaryEquityCarryingAmountAttributableToParent | Temporary Equity, Carrying Amount, Attributable to Parent | USD | 395.80M | 2021-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0001628280-23-007266 | |
| us-gaap | TemporaryEquityLiquidationPreference | Temporary Equity, Liquidation Preference | USD | 335.81M | 2021-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0001628280-23-007266 | |
| us-gaap | TemporaryEquitySharesAuthorized | Temporary Equity, Shares Authorized | shares | 161.42M | 2021-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0001628280-23-007266 | |
| us-gaap | TemporaryEquitySharesIssued | Temporary Equity, Shares Issued | shares | 161.42M | 2021-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0001628280-23-007266 | |
| us-gaap | TemporaryEquitySharesOutstanding | Temporary Equity, Shares Outstanding | shares | 161.42M | 2021-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0001628280-23-007266 | |
| us-gaap | UnrealizedGainLossOnInvestments | Unrealized Gain (Loss) on Investments | USD | 357,000 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0001628280-23-007266 |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued | Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001628280-26-013569 | |
| us-gaap | UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount | Unrecorded Unconditional Purchase Obligation | USD | 136.64M | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-12 | 0001628280-24-047130 | |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 59.64M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001628280-26-013569 |
| us-gaap | VariableLeaseCost | Variable Lease, Cost | USD | 9.45M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001628280-26-013569 |
| us-gaap | WeightedAverageNumberDilutedSharesOutstandingAdjustment | Weighted Average Number Diluted Shares Outstanding Adjustment | shares | 3.20M | 2025-01-01 | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-08 | 0001628280-25-023486 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 177.40M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 177.40M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001628280-26-073392 |